Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial

Vinod Chandran; Vladislav A Malkov; Kaori L Ito; Yihua Liu; Lene Vestergaard; Oh Kyu Yoon; Jinfeng Liu; Mona Trivedi; Angie Hertz; Dafna Gladman

doi:10.1136/rmdopen-2023-003550

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Psoriatic arthritis

Original research

Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Chandran V, Malkov VA, Ito KL, et al

Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial

RMD Open 2023;9:e003550. doi: 10.1136/rmdopen-2023-003550

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password